AZN•benzinga•
A Potential Challenger For AstraZeneca's Blockbuster Lung Cancer Drug?
Summary
AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 20, 2025 by benzinga